FINWIRES · TerminalLIVE
FINWIRES

Barclays Initiates Forte Biosciences at Overweight With $74 Price Target

By

Forte Biosciences (FBRX) has an average rating of buy and mean price target of $66.60, according to analysts polled by FactSet.

What else is happening in Research?